PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Boots introduces new at-home health checks

Boots UK has introduced a range of at-home health checks from Medichecks for various lifestyle issues. The tests have rolled out after a study by Nesta found that...
Continue Reading →
News

Roche’s combination breast cancer treatment delivers positive results

Data from APHINITY study shows Roche’s Perjeta-based regimen reduces the risk of disease returning for people with HER2-positive early breast cancer Roche, the Br...
Continue Reading →
News

EC authorisation granted to kidney disease treatment Kinpeygo

The treatment was developed by Calliditas and will be marketed by Stada The European Commission (EC) has granted conditional marketing authorisation for Kinpeygo ...
Continue Reading →
News

EMA validates application for Byondis’ trastuzumab duocarmazine

The submission follows positive results of phase 3 trial focusing on breast cancer therapy Byondis has announced that the European Medicines Agency (EMA) has vali...
Continue Reading →
News

Monkeypox cases prompt governments to order vaccine supply

Imvanex is a non-replicating smallpox vaccine developed in collaboration with the US government Bavarian Nordic has announced today that a non-disclosed country h...
Continue Reading →
News

AstraZeneca and Daiichi Sankyo’s Enhertu receives EU approval

Specifically engineered antibody treats HER2-positive metastatic breast cancer AstraZeneca and Daiichi Sankyo’s Enhertu – also known as trastuzumab deruxtecan – h...
Continue Reading →
News

NICE recommend’s use of Leo Pharma’s Adtralza

The therapy is for moderate-to-severe atopic dermatitis in adult patients who are candidates for systemic treatment. The National Institute for Health and Care Ex...
Continue Reading →
News

Diabetes patients to benefit from £10m heart disease data investment

The British Heart Foundation’s project will accelerate the search for better prevention and treatment of diabetes. People living with diabetes could be set to ben...
Continue Reading →
News

NICE recommends Janssen’s treatment for active psoriatic arthritis

Clinical trial evidence suggests that Tremfya is effective when compared with a placebo. Tremfya – also known as guselkumab – has been recommended by the National...
Continue Reading →
News

Touchlight signs patent agreement with Pfizer

The deal involves the manufacturing of mRNA-based vaccines, therapeutics and gene therapies. Touchlight, a company which focuses on enzymatic DNA production to fu...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026